An advisory panel to the Centers for Disease Control and Prevention (CDC) remained with their decision to halt the usage of Johnson and Johnson COVID Vaccine in the vaccine rollout. This follows the panel s request for more information regarding J&J s rare blood clot occurrence.
The CDC, along with the U.S. Food and Drug Administration (FDA), recommended the pause of J&J COVID vaccines on Tuesday, after a rare yet serious blood clot occurrence among six people who were inoculated with the vaccine brand, according to an NBC News report. Because of this, all 50 states in the U.S. have temporarily stopped administering Johnson and Johnson.